Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Ah Bio Fund Iii, L.p.
Over the trailing 90 days, Ah Bio Fund Iii, L.p. (10% Owner at Scribe Therapeutics, Inc.) bought $5.0M of stock in SCTX, per 5 SEC Form 4 transactions.
- Role
- 10% Owner
- Companies
- SCTX
- Window
- Trailing 90 days · 5 transactions · CIK 1799477
- Net activity
- +$5.0M ($5.0M bought · $0 sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| SCTX | Scribe Therapeutics, Inc. | 5 | $5.0M | — | $5.0M |
Transactions (5)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-27 | SCTX | Buy | 333.3K | $5.0M | Open market or private purchase |
| 2026-07-27 | SCTX | Buy | 2.1M | $0 | Conversion of derivative security |
| 2026-07-27 | SCTX | Buy | 697.6K | $0 | Conversion of derivative security |
| 2026-07-27 | SCTX | Sell | 4.1M | $0 | Conversion of derivative security |
| 2026-07-27 | SCTX | Sell | 12.2M | $0 | Conversion of derivative security |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Ah's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.